Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Allan Lipton, Susie Jun, Gary Richardson et al.|European Journal of Cancer|2012

Cited by 588